content top

Intravitreal Bevacizumab Injection Alone or Combined with Triamcinolone vs Macular Photocoagulation as Primary Treatment of DME

Purpose: To report the efficacy of a single intravitreal bevacizumab injection alone or in combination with intravitreal triamcinolone acetonide versus macular laser photocoagulation as primary treatment of diabetic macular edema. Methods:   72 eyes of 40 patients with clinically significant DME and no previous treatment were enrolled. The eyes were randomly assigned to one of three study arms: the intravitreal bevacizumab (IVB) group,...

Read More

A Comparison of Brilliant Blue G, Triamcinolone and Indocyanine Green Dyes to Assist ILM Peeling During Macular Hole Surgery

Purpose: To compare surgical outcomes with three dyes, brilliant blue G (BBG), triamcinolone (TA) and indocyanine green (ICG), used to facilitate internal limiting membrane peeling during macular hole surgery. Methods: This comparative, interventional cases series consisted of 30 eyes of 26 patients with senile idiopathic macular holes, who underwent 23 G vitrectomy with internal limiting membrane peeling. We compared the intraoperative...

Read More

Phaco-vitrectomy with Internal Limiting Membrane Peeling for Full-thickness Macular Holes

Kubilhan Elmas, Özgür Bilen Basaran, Ali Altýnsoy (Ankara, Turkey) We reviewed the records of 17 consecutive patients (17 eyes) who underwent phacoemulsification and 23 gauge pars plana vitrectomy with ILM peeling in one session for repair of macular hole. The mean age of the patients was 66 (range 52 to 78) years. The mean duration of macular holes prior to surgery was 8 months. 12 holes closed, 5 remained opened. All patients except...

Read More

Intravitreal Bevacizumab for Treatment of Chronic Central Serous Chorioretinopathy

Kubilhan Elmas, Özgür Bilen Basaran, Ali Altýnsoy (Ankara, Turkey) The purpose of this study was to evaluate the effectiveness of intravitreal injection of bevacizumab for treatment of central serous chorioretinopathy. Seven eyes of 7 patients with chronic central serous chorioretinopathy received an intravitreal bevacizumab (1.25 mg/0.05 ml) injection. At baseline and follow-up visits patients had best corrected visual acuity (BCVA),...

Read More

Bilateral Subinternal Limiting Membrane Hemorrhage with Terson Syndrome

Kubilhan Elmas, Özgür Bilen Basaran, Ali Altýnsoy (Ankara, Turkey) Purpose: To report the anatomic location of bilateral dome-shaped posterior pole hemorrhages in a patient with Terson syndrome. Methods: Case report. We performed bilateral vitrectomy for vitreous hemorrhage in a patient with Terson syndrome. After removal of vitreous hemorrhage, the tissue overlying a large discrete hemorrhage in the posterior pole was...

Read More

Efficacy of Intravitreal Bevacizumab in Treating Postoperative Pseudophakic Cystoid Macular Edema

Kubilhan Elmas, Özgür Bilen, Ali Altýnsoy (Ankara, Turkey) Purpose: To describe the efficacy of intravitreal bevacizumab (Avastin) in patients with cystoid macular edema (CME) after cataract surgery (Irvine-Gass syndrome). Methods: This retrospective case series comprised 8 eyes of 8 patients with CME after cataract surgery refractory to current standard treatment that received an injection of 1.25 mg intravitreal Avastin. The main...

Read More

Intravitreal Triamcinolone and Bevacizumab Injection for Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion

Kubilhan Elmas, Özgür Bilen, Ali Altýnsoy (Ankara, Turkey) Purpose: To evaluate the efficacy of intravitreal triamcinolone injection in eyes with macular edema due to branch retinal vein occlusion (BRVO) over a 1-year period. Methods: The authors performed a retrospective chart review of 18 eyes of 18 patients (mean age 71 years) who underwent intravitreal injections with 2 mg triamcinolone acetonide and 1,25 mg bevacizumab for macular...

Read More

The Combination of Intravitreal Bevacizumab and Phacoemulsification Surgery in Patients with Cataract and Coexisting Diabetic Macular Edema

Ozgür Bilen, Kubilhan Elmas, Ali Altýnsoy (Ankara, Turkey) Purpose: The aim of this study was to assess the efficacy of phacoemulsification combined with intravitreal bevacizumab injection in diabetics with clinically significant macular edema (CSME) and cataract. Methods: This retrospective study included diabetic patients with cataract and CSME who underwent phacoemulsification and intraocular lens implantation with a 1,25-mg...

Read More

Intravitreal Triamcinolone Acetonide for Macular Edema Owing to Retinal Vein Occlusion

Ozgür Bilen, Kubilhan Elmas, Ali Altýnsoy (Ankara, Turkey) Purpose: To assess the long-term safety and efficacy of intravitreal triamcinolone acetonide injection in the management of macular edema caused by branch retinal vein occlusion. Methods: This retrospective case series included 11 patients (11 eyes) with retinal vein occlusion and macular edema. They received an intravitreal injection of 4 mg triamcinolone acetonide. Follow-up...

Read More

Comparison of Effect of Cataract Surgery with Bevacizumab Alone and Combined with Intravitreal Triamcinolone on Progression of Diabetic Retinopathy

Authors: Elmas Kubilhan, Bilen Özgür, Arsen Akýncý, Ersel Özkýlýç, Ali Altýnsoy, Ankara, Turkey Advantages / Purpose: To study the effect of Cataract Surgery with Bevacizumab alone and Combined with Intravitreal triamcinolone Injection on Progression of Diabetic Retinopathy. Setting: Kudret Eye Hospital, Ankara. Methods: Cataract surgery with phacoemulsification was performed in 52 eyes of 44 patients who had diabetic retinopathy....

Read More

Macular Hole Hurgery with Inverted Internal Limiting Membrane Peeling Technique

Authors: Elmas Kubilhan, Bilen Özgür, Arsen Akýncý, Ersel Özkýlýç, Ali Altýnsoy, Ankara, Turkey Purpose: To study effect of inserting part of the internal limiting membrane to macular hole to form a bridge. Methods: In a prospective study the records of a consecutive series of 5 patients with full-thickness idiopathic macular holes operated with ICG-assisted ILM peeling by a single surgeon were analyzed. All patients underwent a...

Read More
content top